UK strikes pact for 60 million doses of COVID-19 experimental vaccine
News

UK strikes pact for 60 million doses of COVID-19 experimental vaccine

Newsdesk |
July 30, 2020

The UK government on Wednesday announced an early access agreement with GlaxoSmithKline (GSK) and Sanofi Pasteur for an estimated 60 million doses of an experimental new vaccine being tested to combat COVID-19. The agreement with Britain's GSK and France's Sanofi, which combined have among the largest vaccine manufacturing capabilities in the world, will supply the UK with 60 million doses of their vaccine based on existing DNA-based technology used to produce Sanofi's flu vaccine.


New Delhi, 30 July 2020

As per news report of PTI, while it remains uncertain as to which, if any, of the anti-coronavirus vaccines under various stages of development around the world will ultimately work, the British government said the latest deal helps grow the country's portfolio of vaccine candidates and adds to previous agreements.

Source -PTI


Read More >>


If you like the story and if you wish more such stories, support our effort Make a donation.




Loading...

If you believe investigative journalism is essential to making democracy functional and accountable support us. »